Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Germany Lures Hospitals To DRGs Despite Modest Implementation Resources

This article was originally published in The Gray Sheet

Executive Summary

Legislation under consideration in Germany will exclude hospitals joining an optional DRG establishment period in 2003 from a freeze on health care funds, providing hesitant centers an incentive to join the system, according to device association BVMed

You may also be interested in...



International News In Brief

MHRA leadership: Alasdair Breckenridge is appointed chair-designate of UK's Medicines and Healthcare products Regulatory Agency Nov. 28. The pharmacology professor has served for the Committee on the Safety of Medicines since 1984 and as chairman since 1999. He has an "excellent understanding of the regulation of pharmaceutical products," DoH says. Breckenridge still must acquire a similar knowledge of medical equipment regulation, however, as consolidation of the Medical Devices Agency and the Medicines Control Agency is expected to retain MDA's focus on devices (1"The Gray Sheet" Sept. 30, 2002, p. 15). One of Breckenridge's first tasks will be to recruit MHRA's first chief executive and a new board...

International News In Brief

MHRA leadership: Alasdair Breckenridge is appointed chair-designate of UK's Medicines and Healthcare products Regulatory Agency Nov. 28. The pharmacology professor has served for the Committee on the Safety of Medicines since 1984 and as chairman since 1999. He has an "excellent understanding of the regulation of pharmaceutical products," DoH says. Breckenridge still must acquire a similar knowledge of medical equipment regulation, however, as consolidation of the Medical Devices Agency and the Medicines Control Agency is expected to retain MDA's focus on devices (1"The Gray Sheet" Sept. 30, 2002, p. 15). One of Breckenridge's first tasks will be to recruit MHRA's first chief executive and a new board...

International News In Brief

Marjory Searing: AdvaMed names former Clinton administration trade advisor VP-global strategy & analysis. Currently senior-VP at Civic Service, Inc., a Japan-focused consulting firm, Searing begins Dec. 2 at AdvaMed, where she succeeds Ed Rozynski (1"The Gray Sheet" April 19, 2002, In Brief). With 27 years of experience at the Treasury Department and Department of Commerce, including a post as deputy assistant secretary for Asia, Searing has worked on the market-oriented, sector-selective (MOSS) agreements to improve market access for medical products in Japan...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017447

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel